MarketCapTrends
COLL

Collegium Pharmaceutical Inc. (COLL)

NASDAQ · Healthcare

Collegium Pharmaceutical Inc. annual/quarterly shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Collegium Pharmaceutical Inc. shareholder equity for the quarter ending December 31, 2025 were 301.7M, a 31.83% increase year-over-year.
  • Collegium Pharmaceutical Inc. shareholder equity for 2025 were 301.7M, a 31.83% increase from 2024.
  • Collegium Pharmaceutical Inc. shareholder equity for 2024 were 228.8M, a 17.10% increase from 2023.
  • Collegium Pharmaceutical Inc. shareholder equity for 2023 were 195.4M, a 0.30% increase from 2022.
  • Collegium Pharmaceutical Inc. shareholder equity for 2022 were 194.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Collegium Pharmaceutical Inc. Annual Shareholder Equity (Millions of US $)
2025$302
2024$229
2023$195
2022$195
2021$203
2020$186
2019$87
2018$92
2017$104
2016$135
Collegium Pharmaceutical Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$302
2024-12-31$229
2023-12-31$195
2022-12-31$195
2021-12-31$203
2020-12-31$186
2019-12-31$87
2018-12-31$92
2017-12-31$104
2016-12-31$135

Collegium Pharmaceutical Inc. Shareholder Equity — FAQ

Collegium Pharmaceutical Inc. (COLL) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see COLL's shareholder equity history?

The chart and table above show Collegium Pharmaceutical Inc.'s shareholder equity by year and by quarter, including the growth rate.